Cytek Biosciences Narrows FY2026 Sales Guidance from $207.000M-$212.000M to $208.000M-$211.000M vs $209.415M Est
Benzinga Newsdesk 3 hours ago
NewsGuidance
Cytek Biosciences (NASDAQ:CTKB) narrows FY2026 sales outlook from $207.000 million-$212.000 million to $208.000 million-$211.000 million vs $209.415 million estimate.
Cytek Biosciences (NASDAQ:CTKB) narrows FY2026 sales outlook from $207.000 million-$212.000 million to $208.000 million-$211.000 million vs $209.415 million estimate.